TLDR:
- Tempus AI stock surged 35.5% to $47.64 following launch of AI health concierge app olivia
- Nancy Pelosi’s purchase of 50 call options with $20 strike price boosted investor confidence
- Company expects 2024 revenue of $693 million, up 30% from previous year
- New olivia app integrates with over 1,000 healthcare systems and digital health devices
- Stock is up 16% over past year but remains 40% below November peak
Tempus AI (NASDAQ: TEM) shares jumped 35.5% on Tuesday, reaching $47.64 in their largest single-day gain since the company’s June IPO. The surge followed the launch of the company’s AI-powered health concierge app and the disclosure of a options position by former House Speaker Nancy Pelosi.
The company unveiled olivia, an AI-enabled personal health concierge app that centralizes patients’ health data and provides actionable insights. The platform integrates with popular fitness devices like Apple Watch and Google Fit while connecting to over 1,000 healthcare systems.
Tempus CEO Eric Lefkofsky emphasized that olivia goes beyond basic data organization, serving as a proactive healthcare partner. The app can track daily health metrics, compile clinical histories, and transcribe medical appointments.
The stock received additional momentum from Nancy Pelosi’s disclosure of purchasing 50 call options with a $20 strike price expiring in January 2026. The trade was valued between $50,000 and $100,000.

Pelosi’s investment track record has drawn market attention, with her portfolio gaining 70.9% in 2024, outperforming the S&P 500’s 25% return. The former House Speaker’s trading activities are closely monitored by investors.
The timing of olivia’s launch aligns with Wall Street’s evolving AI narrative. Goldman Sachs analysts predict 2025 will mark “Phase 3” of the AI revolution, where benefits extend beyond infrastructure companies to software firms developing autonomous AI agents.
Tempus recently announced preliminary results for 2024, projecting revenue growth of 30% to reach $693 million. The company’s stock performance has been mixed since its June IPO, showing 16% growth over the past year while remaining 40% below its November peak.
The olivia platform represents Tempus’s entry into the growing market for AI-powered healthcare management tools. The app aims to simplify patient care by consolidating electronic health records and providing AI-driven insights.
Market response to the launch suggests growing confidence in AI applications within healthcare. The platform’s ability to integrate with multiple healthcare systems positions Tempus to potentially capture a larger share of the digital health market.
Pelosi’s investment disclosure included other technology companies, with positions taken in Vistra, Palo Alto Networks, Alphabet, Amazon, and Nvidia. She also sold portions of her holdings in Nvidia and Apple at the end of 2024.
The healthcare software company’s stock movement reflects broader market interest in AI-driven healthcare solutions. Tempus’s focus on practical applications of AI technology aligns with industry trends toward personalized healthcare management.
Trading volume increased during Tuesday’s session as investors responded to both the product launch and Pelosi’s investment. The stock’s performance marked its strongest trading day since becoming publicly traded.
The company’s integration capabilities with major fitness tracking devices suggest potential for expanded consumer adoption. Tempus emphasizes the platform’s ability to provide actionable insights based on collected health data.
Stay Ahead of the Market with Benzinga Pro!
Want to trade like a pro? Benzinga Pro gives you the edge you need in today's fast-paced markets. Get real-time news, exclusive insights, and powerful tools trusted by professional traders:
- Breaking market-moving stories before they hit mainstream media
- Live audio squawk for hands-free market updates
- Advanced stock scanner to spot promising trades
- Expert trade ideas and on-demand support